About

China Grand Enterprises is an enterprise whose business interests now cover healthcare, real estate, financial services and trade. It is also the parent company of three publicly traded companies: China Grand Pharmaceutical and Healthcare Holdings, Huadong Medicine and Grand Industrial Holding. Shi Yingchun has served the company as legal president for over seven years and is credited with establishing the legal management model to cover China Grand Enterprises’ major projects as well as its business administration affairs, stock equity management, intellectual property management and security operations management. He has also been commended for his efforts in enhancing and standardising the contract management and review systems and for his expertise in international cases such as NASDAQ listings and de-listing processes. Another of Shi’s major contributions was during the work associated with the acquisition of large international companies and domestic enterprises, including companies across Europe, Latin America and the US. Not only has Shi played an important role in M&A deals, but he has also saved China Grand Enterprises substantial potential losses by resolving challenging litigation and disputes involving the company and its subsidiaries. Before his current role, Shi had spells as a partner in Beijing ShiChen Law Firm, legal manager at Century 21 China Headquarters, and the vice director and partner in Shandong JuePing Law Firm. Over the course of 20 years, effectively applying legal theory with business management has been a key feature of his legal work.